- Guillaume Pfefer, Ph.D., MBA to serve as CEO; John Mendlein, Ph.D. to serve as Executive Chairman Sail unites Laronde and Senda Biosciences, two companies that deliver more than eight years of ...

BOSTON--(BUSINESS WIRE)--Nanite Inc. announced today the closing of a $6M seed investment round to advance their AI-driven polymer design platform focused on next-generation, non-viral gene delivery.

Not only can these particles be transformed into tooth-cleaning shapes, but their action can have antimicrobial effects that destroy plaque-causing bacteria. Share on Facebook (opens in a new window) ...

SOMERVILLE, Mass.--(BUSINESS WIRE)--Sail Biomedicines, Inc. (“Sail”), a Flagship Pioneering company and leader in RNA-based programmable medicines, today announced that Kerry Benenato, Ph.D., has been ...

Nature is the ultimate inspiration for innovators, including those who would emulate biology to realize applications in the life sciences. Indeed, some of the most intrepid innovators are those who ...

Case Western Reserve University chemist Divita Mathur was awarded a National Science Foundation (NSF) Faculty Early Career Development Program (CAREER) grant for her research in synthetic DNA ...

The field of genetic therapies seems to be making a collective shift toward the exploration of delivery systems—and the Cystic Fibrosis Foundation (CFF) is no different. The nonprofit recently ...

CLEVELAND—Case Western Reserve University chemist Divita Mathur was awarded a National Science Foundation (NSF) Faculty Early Career Development Program (CAREER) grant for her research in synthetic ...

TEL AVIV, Israel, Oct. 10, 2023 /PRNewswire/ -- Mana.bio, a biotechnology company accelerating programmable drug delivery, today unveiled its AI-based lipid nanoparticle (LNP) delivery platform to ...

CAMBRIDGE, Mass., Oct. 19, 2023 /PRNewswire/ -- Flagship Pioneering today announced the combination of Laronde and Senda Biosciences to launch Sail Biomedicines, a company pioneering the design and ...